
MapLight Therapeutics Inc
MPLTHealthcare|Biotechnology|USA
$39.28
-0.48 (-1.21%)
Tangible Book
$8.84
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
null,
null,
null
],
"net_income_estimate": [
null,
null,
null
],
"ebit_estimate": [
-189.5,
-154,
-195.5
],
"ebitda_estimate": [
-267.4,
-285.5,
-289
],
"per_share_eps_estimate": [
-5.285,
-5.245,
-4.47
],
"eps_nri_estimate": [
-5.285,
-5.245,
-4.47
],
"dividend_estimate": [
null,
null,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null
],
"pretax_income_estimate": [
null,
null,
null
],
"roa_estimate": [
null,
null,
null
],
"roe_estimate": [
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null
],
"pettm_estimate": [
0,
0,
0
],
"operating_cash_flow_estimate": [
null,
null,
null
],
"long_term_growth_rate_mean": 34.81,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": 34.81,
"future_eps_nri_estimate_growth": 34.81,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": -18.34,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"net_income_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"ebit_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"ebitda_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"per_share_eps_estimate": [
-1.43,
-1.26,
-1.27,
-1.35,
-1.39,
-1.32,
-1.22
],
"eps_nri_estimate": [
-1.43,
-1.26,
-1.27,
-1.35,
-1.39,
-1.32,
-1.22
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
0,
0,
0
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"long_term_growth_rate_mean": 34.81,
"long_term_revenue_growth_rate_mean": "0.00",
"future_per_share_eps_estimate_growth": 34.81,
"future_eps_nri_estimate_growth": 34.81,
"future_revenue_estimate_growth": null,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": -18.34,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}